P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment

P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment

Item
http://www.wikidata.org/entity/Q39499956
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factorsBrilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected?Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophyP2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophyOral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice.Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy.A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.Purinergic signalling in the musculoskeletal system.Dystrophin: The dead calm of a dogma.Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.Sustained activation of P2X7 induces MMP-2-evoked cleavage and functional purinoceptor inhibition.The P2X7 Receptor.A need for NAD+ in muscle development, homeostasis, and aging.Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
P2860

P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment

Item
http://www.wikidata.org/entity/Q39499956
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
P2X7 purinoceptor alterations ...... potential target for treatment
@en
P2X7 purinoceptor alterations ...... otential target for treatment.
@nl
type
label
P2X7 purinoceptor alterations ...... potential target for treatment
@en
P2X7 purinoceptor alterations ...... otential target for treatment.
@nl
prefLabel
P2X7 purinoceptor alterations ...... potential target for treatment
@en
P2X7 purinoceptor alterations ...... otential target for treatment.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
P2X7 purinoceptor alterations ...... potential target for treatment
@en
P2093
P2860
P304
P31
P356
10.1111/J.1582-4934.2011.01397.X
P433
P478
P50
P577
P5875
P698
P921
P932